Worldwide Frozen Tissues Samples Industry to 2028 – Increasing Application of Frozen Tissue Samples due to Rising Prevalence of Cancer – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Frozen Tissues Samples Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product Type, Application and End User” report has been added to ResearchAndMarkets.com’s offering. The frozen tissues samples market is projected to reach US$ 105,045.91 Thousand by 2028 from US$ 44,399.07 Thousand in 2021; it is estimated to grow at … [Read more…]

St. Peter’s Health Moves to the Innovaccer Health Cloud to Optimize Care Management and Collaboration Across Care Sites

Regional integrated health system chooses the Innovaccer 2022 Best in KLAS data platform to provide solutions for enhanced provider-patient collaboration and patient engagement. SAN FRANCISCO–(BUSINESS WIRE)–Today, Innovaccer Inc., the Health Cloud company, announced that St. Peter’s Health, a regional nonprofit healthcare system in Helena, Montana, is moving to the InnovaccerⓇ Health Cloud’s Data Activation Platform … [Read more…]

Global Photoacoustic Tomography Market Forecast to 2028 – COVID-19 Impact and Analysis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Photoacoustic Tomography Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Geometry, Type, Application and End User” report has been added to ResearchAndMarkets.com’s offering. The photoacoustic tomography market is projected to reach US$ 209.56 million by 2028 from US$ 61.12 million in 2021; it is expected to grow at a CAGR … [Read more…]

Oncomatryx Announces FDA and AEMPS IND Clearance for OMTX705, a First-in-class Tumor Microenvironment-targeted ADC, to Treat Advanced Solid Tumors

BILBAO, Spain–(BUSINESS WIRE)–After 15 years of pioneering R&D efforts in the tumor microenvironment, Oncomatryx announces that the FDA and the Spanish Drug Agency (AEMPS) have cleared its investigational new drug (IND) application for OMTX705, a First-in-Class antibody-drug conjugate (ADC) targeting the tumor microenvironment. OMTX705 is a pioneering ADC that targets, with a novel, dual mechanism … [Read more…]

AXIS Combines Supplemental Health and Corporate Accident Business Units and Signals Ambitions for Growth with Launch of AXIS Group Benefits

PEMBROKE, Bermuda–(BUSINESS WIRE)–$AXS #insurance–AXIS Insurance, the specialty insurance business segment of AXIS Capital Holdings Limited (“AXIS Capital”) (NYSE: AXS), today announced it is combining its corporate accident and supplemental health benefits business under a new name, AXIS Group Benefits. The AXIS Group Benefits business portfolio will be managed by the newly expanded team, providing a … [Read more…]

Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay for Lung Cancer at 2022 ASCO Annual Meeting

Company to present on extended applications of ultrasensitive liquid biopsy assays at 2022 ASCO in Chicago CHICAGO–(BUSINESS WIRE)–#asco–Lucence, the precision oncology company pioneering ultrasensitive liquid biopsy tests using circulating tumor DNA (ctDNA) and circulating tumor RNA (ctRNA), will present promising new data on the extension of its amplicon-based next generation sequencing (NGS) assays to new … [Read more…]

GRAIL Announces Collaboration With U.S. Department of Veterans Affairs and the Veterans Health Foundation to Evaluate Galleri® Multi-Cancer Early Detection Test

Collaboration Will Provide Galleri Test to 10,000 Veterans Across the U.S. Over the Next Three Years; VA Pittsburgh Healthcare System Announced as First of Approximately 10 Participating Sites Collaboration is Part of REFLECTION, a Real-World Observational Study Evaluating Performance of Galleri in Clinical Settings MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL, LLC, a healthcare company whose mission is … [Read more…]

AMN Healthcare Survey: Most Healthcare Facilities Using Locum Tenens Physicians to Fill Vacancies

DALLAS–(BUSINESS WIRE)–Nearly 90% of healthcare facilities used locum tenens physicians and/or advanced practice professionals to fill gaps in their staffs last year, according to a new survey from AMN Healthcare, the nation’s leader in total healthcare talent solutions. The company’s 2022 Survey of Locum Tenens Staffing Trends indicates that 88% of hospitals, medical groups, and … [Read more…]

Edgewise Therapeutics to Present at Upcoming Investor Conferences

BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders, announced today that members of its senior management team will participate in the following upcoming investor conferences: Jefferies Healthcare Conference Presentation: Friday, June 10, 2022, at 10 am ET … [Read more…]

LifeWorks iCBT Program to be offered through Johns Hopkins Balance program for mental health

LifeWorks delivers innovative, flexible, effective mental health support through smartphone, tablet or computer CHICAGO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person mental health and total wellbeing solutions, today announced a new collaboration with Johns Hopkins Medicine HealthCare Solutions. Johns Hopkins will offer the LifeWorks internet-based cognitive behavioral therapy (iCBT) solution as a component of … [Read more…]